Adherence to CPAP therapy in Down syndrome: the population-based DISCOVERY study
Journal of Clinical Sleep Medicine · 2023-03 · 19 (3) · 453-458
DOI: 10.5664/jcsm.10364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Sleep Medicine, 2023-03. Verfasst von Malin Svensson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research and Development, Uppsala University, Region of Gävleborg, Gävle Hospital, Gävle, Sweden. Hauptthemen laut MEDLINE: Down Syndrome, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
STUDY OBJECTIVES: Persons with Down syndrome (DS) have an increased risk of obstructive sleep apnea (OSA) needing continuous positive airway pressure (CPAP), but data on the therapy and outcomes in this population are scarce. We aimed to compare patient characteristics and outcomes of CPAP treatment for patients with OSA with and without DS. METHODS: This was a population-based, longitudinal study on patients initiating CPAP therapy between July 2010 and March 2018 in Sweden and a population-based sex- and age-matched control group (control:case ratio 5:1), with linked data from the Swedish National Patient Registry and the Prescribed Drug Registry (DISCOVERY study cohort). RESULTS: Patients with DS (n = 64) had a higher apnea-hypopnea index (51.7 ± 30.3 vs 36.8 ± 29.1 events/h, P < .001), Epworth Sleepiness Scale score (13.7 ± 5.9 vs 11.0 ± 4.9, P = .001), rate of previous surgery of tonsils and/or adenoids (21.9% vs 8.2%, P = .001), and more thyroid replacement hormone therapy (45.3% vs 7.8%, P < .001), but lower use of cardiovascular drugs (7.8% vs 22.3%, P = .003) compared with controls. At follow-up after 1.3 ± 0.9 years, there were no differences in nocturnal CPAP usage time (5.6 ± 2.4 vs 5.5 ± 2.0 hours, P = .77), CPAP adherence ≥ 4 hours/night (62% vs 65%, P = .93), or improvement in Epworth Sleepiness Scale score (-5.4 ± 6.8 vs -5.0 ± 2.0, P = .84) between DS and non-DS patients. CONCLUSIONS: OSA severity was substantially higher in patients with DS despite an increased rate of tonsil surgery. Treatment outcomes in terms of adherence and improved daytime sleepiness were comparable between groups, underlining the importance of both OSA diagnosis and treatment in patients with DS. CITATION: Svensson M, Ekström M, Sundh J, Ljunggren M, Grote L, Palm A. Adherence to CPAP therapy in Down syndrome: the population-based DISCOVERY study. J Clin Sleep Med. 2023;19(3):453-458.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Research and Development, Uppsala University, Region of Gävleborg, Gävle Hospital, Gävle, Sweden.
- Department of Otorhinolaryngology, Head and Neck Cancer, Uppsala University, Uppsala, Sweden.
- Department of Clinical Sciences, Respiratory Medicine, Allergology and Palliative Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
- Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro Sweden.
- Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
- Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Zitieren
APA
Svensson, M., Ekström, M., Sundh, J., Ljunggren, M., Grote, L., & Palm, A. (2023). Adherence to CPAP therapy in Down syndrome: the population-based DISCOVERY study. Journal of Clinical Sleep Medicine, 19(3), 453-458. https://doi.org/10.5664/jcsm.10364
Vancouver
Svensson M, Ekström M, Sundh J, Ljunggren M, Grote L, Palm A. Adherence to CPAP therapy in Down syndrome: the population-based DISCOVERY study. Journal of Clinical Sleep Medicine. 2023;19(3):453-458. doi:10.5664/jcsm.10364
BibTeX
@article{Svensson2023,
author = {Svensson, Malin and Ekström, Magnus and Sundh, Josefin and Ljunggren, Mirjam and Grote, Ludger and Palm, Andreas},
title = {Adherence to CPAP therapy in Down syndrome: the population-based DISCOVERY study},
journal = {Journal of Clinical Sleep Medicine},
year = {2023},
volume = {19},
number = {3},
pages = {453--458},
doi = {10.5664/jcsm.10364}
}
EUVIMED